Memorial Sloan Kettering Cancer Center, New York, NY 10065; email:
Annu Rev Med. 2015;66:297-309. doi: 10.1146/annurev-med-050913-022228.
Obesity is a leading modifiable risk factor for the development of several epithelial malignancies. In addition to increasing risk, obesity also confers worse prognosis for many cancers. Obesity represents an overall state of energy imbalance frequently associated with systemic effects including insulin resistance, altered hormone signaling, and high circulating levels of proinflammatory mediators. In addition to its systemic effects, obesity causes subclinical white adipose inflammation including increased tissue levels of proinflammatory mediators. Both local and systemic effects are likely to contribute to the development and progression of cancer. An understanding of the interplay between local and systemic alterations involved in the obesity-cancer link provides the basis for developing interventions aimed at mitigating the protumorigenic effects.
肥胖是多种上皮恶性肿瘤发生的主要可改变风险因素。肥胖不仅会增加癌症风险,还会导致预后更差。肥胖代表一种能量失衡的整体状态,常伴有全身性影响,包括胰岛素抵抗、激素信号改变和促炎介质循环水平升高。除全身性影响外,肥胖还会引起亚临床白色脂肪炎症,包括组织内促炎介质水平升高。局部和全身性影响都可能导致癌症的发生和发展。了解肥胖与癌症关联中涉及的局部和全身性改变之间的相互作用,为开发旨在减轻促肿瘤效应的干预措施提供了基础。